Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 7673 - 7680 of 12107 results

With the passage of Proposition 67, the question is "Would you like paper or…paper?"

November 15, 2016| Blog| Viewpoint

FDA to Study Social Media Promotion

November 15, 2016| Blog| Viewpoint

Transitioning the Affordable Care Act: Republicans Must Talk to Insurers

November 15, 2016| Blog| Viewpoint

Failure to Let Patent Owner Address Unpatentability Arguments Relied on by the Board Violates Administrative Procedures

November 15, 2016| Blog| Viewpoint

'Joint employer' lawsuit vs Amazon, trucking companies illustrates reach of doctrine pushed by NLRB

November 15, 2016| News

Recent Developments around Pharmaceutical Drug Spending in Massachusetts

November 14, 2016| Alert| Viewpoint

USCIS Revises Form I-9

November 14, 2016| Alert| Viewpoint

It’s Not Really ”Repeal and Replace”; It’s Transition

November 14, 2016| Blog| Viewpoint

News & Press Releases

Mintz Honored with NLADA Beacon of Justice Award

August 21, 2025

Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.

SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals

August 19, 2025

Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.

Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree

August 19, 2025

Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.

View all News and Press Releases